stock
None
NASDAQ:BIIB
291.71
-1.49 (-0.51%)
As of 2021-09-24 Close (EST)
52 Week Rng -
Market Cap -
Avg Volume -
1M Volatility -
Short Ratio -
P/E Ratio (TTM) -
P/E Ratio (Fwd) -
P/B Ratio -
Div & Yield -
[SELL]
3
Filled
ACTION
TICKER
SHARES
STATUS
BUY
25
Filled
ACTION
TICKER
SHARES
STATUS
[BUY]
148
Filled
ACTION
TICKER
SHARES
STATUS
[SELL]
100
Filled
ACTION
TICKER
SHARES
STATUS
[SELL]
15
Filled
ACTION
TICKER
SHARES
STATUS
[BUY]
100
Filled
ACTION
TICKER
SHARES
STATUS
[BUY]
3
Filled
ACTION
TICKER
SHARES
STATUS
[BUY]
500
Filled
ACTION
TICKER
SHARES
STATUS
BUY
50
Filled
ACTION
TICKER
SHARES
STATUS

caitlinsheng Abington 2021 Apr 2021

New experimental ALS medicine could be revolutionary

SELL
20
Filled
ACTION
TICKER
SHARES
STATUS

InvestmentTeam2 Stockfuse Continuum (US) Apr 2021

Closing all the open orders from the investment game.

BUY
6
×
ACTION
TICKER
SHARES
STATUS
BUY
10
Filled
ACTION
TICKER
SHARES
STATUS
BUY
20
Filled
ACTION
TICKER
SHARES
STATUS

InvestmentTeam2 BU52043 Investment Game 2020/21 Feb 2021

A best value stock. Company focuses on discovery, development and commercialization of pharmaceutical treatments with a strong focus on neurology, oncology and immunology. Has a PE ratio of 9.1

[BUY]
576
Filled
ACTION
TICKER
SHARES
STATUS
BUY
20
Filled
ACTION
TICKER
SHARES
STATUS
[SELL]
25
Filled
ACTION
TICKER
SHARES
STATUS
BUY
10
Filled
ACTION
TICKER
SHARES
STATUS
[SELL]
25
Filled
ACTION
TICKER
SHARES
STATUS
BUY
150
Filled
ACTION
TICKER
SHARES
STATUS
BUY
2
Filled
ACTION
TICKER
SHARES
STATUS
more
AAPL AMZN GILD NFLX TSLA CMG AAPL AWR AWK BAC
Market data provided by Xignite, BATS BZX Real-Time Price, and SIX Financial Information.